Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Solid organ transplantation has been rapidly developed as a therapeutic intervention that is life-saving and greatly contributes to a better quality of life in organ recipients. Organ transplant immunosuppressant drugs can prevent organ rejection post transplantation.
The report details the trend, potential and market size of Organ Transplant Immunosuppressant Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Organ Transplant Immunosuppressant Drugsmarket, defines the market attractiveness level of Organ Transplant Immunosuppressant Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Organ Transplant Immunosuppressant Drugs industry, describes the types of Organ Transplant Immunosuppressant Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Organ Transplant Immunosuppressant Drugs market and the development prospects and opportunities of Organ Transplant Immunosuppressant Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Organ Transplant Immunosuppressant Drugs market in Chapter 13.
By Player:
Hoffmann-La Roche Ltd
Novartis AG
Astellas Pharma, Inc
Janssen Pharmaceutical
Allergan plc
AbbVie, Inc
Veloxis Pharmaceuticals
GlaxoSmithKline plc
Pfizer, Inc
Sanofi
Bristol-Myers Squibb Company
F Hoffmann-La Roche Ltd
By Type:
Antibodies
Antiproliferative Agents
Calcineurin Inhibitors
mTOR Inhibitors
Steroids
By End-User:
Bone Marrow Transplant
Heart Transplant
Kidney Transplant
Liver Transplant
Lung Transplant
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Organ Transplant Immunosuppressant Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Organ Transplant Immunosuppressant Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Organ Transplant Immunosuppressant Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Organ Transplant Immunosuppressant Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Organ Transplant Immunosuppressant Drugs Market Analysis and Outlook to 2022
-
7.1 Global Organ Transplant Immunosuppressant Drugs Consumption (2017-2022)
-
7.2 United States Organ Transplant Immunosuppressant Drugs Consumption (2017-2022)
-
7.3 Europe Organ Transplant Immunosuppressant Drugs Consumption (2017-2022)
-
7.4 China Organ Transplant Immunosuppressant Drugs Consumption (2017-2022)
-
7.5 Japan Organ Transplant Immunosuppressant Drugs Consumption (2017-2022)
-
7.6 India Organ Transplant Immunosuppressant Drugs Consumption (2017-2022)
-
7.7 South Korea Organ Transplant Immunosuppressant Drugs Consumption (2017-2022)
8 Region and Country-wise Organ Transplant Immunosuppressant Drugs Market Analysis and Outlook to 2028
-
8.1 Global Organ Transplant Immunosuppressant Drugs Consumption Forecast (2022-2028)
-
8.2 United States Organ Transplant Immunosuppressant Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Organ Transplant Immunosuppressant Drugs Consumption Forecast (2022-2028)
-
8.4 China Organ Transplant Immunosuppressant Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Organ Transplant Immunosuppressant Drugs Consumption Forecast (2022-2028)
-
8.6 India Organ Transplant Immunosuppressant Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Organ Transplant Immunosuppressant Drugs Consumption Forecast (2022-2028)
9 Global Organ Transplant Immunosuppressant Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Organ Transplant Immunosuppressant Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antiproliferative Agents Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Calcineurin Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Steroids Consumption and Growth Rate (2017-2022)
-
9.2 Global Organ Transplant Immunosuppressant Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Bone Marrow Transplant Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Heart Transplant Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Kidney Transplant Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Liver Transplant Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Lung Transplant Consumption and Growth Rate (2017-2022)
10 Global Organ Transplant Immunosuppressant Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Organ Transplant Immunosuppressant Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antiproliferative Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Calcineurin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Steroids Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Organ Transplant Immunosuppressant Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Bone Marrow Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Heart Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Kidney Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Liver Transplant Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Lung Transplant Consumption Forecast and Growth Rate (2022-2028)
11 Global Organ Transplant Immunosuppressant Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Organ Transplant Immunosuppressant Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Organ Transplant Immunosuppressant Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Organ Transplant Immunosuppressant Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Organ Transplant Immunosuppressant Drugs Market Competitive Analysis
-
14.1 Hoffmann-La Roche Ltd
-
14.1.1 Hoffmann-La Roche Ltd Company Details
-
14.1.2 Hoffmann-La Roche Ltd Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Hoffmann-La Roche Ltd Organ Transplant Immunosuppressant Drugs Product and Service
-
14.2 Novartis AG
-
14.2.1 Novartis AG Company Details
-
14.2.2 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis AG Organ Transplant Immunosuppressant Drugs Product and Service
-
14.3 Astellas Pharma, Inc
-
14.3.1 Astellas Pharma, Inc Company Details
-
14.3.2 Astellas Pharma, Inc Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Astellas Pharma, Inc Organ Transplant Immunosuppressant Drugs Product and Service
-
14.4 Janssen Pharmaceutical
-
14.4.1 Janssen Pharmaceutical Company Details
-
14.4.2 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Product and Service
-
14.5 Allergan plc
-
14.5.1 Allergan plc Company Details
-
14.5.2 Allergan plc Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Allergan plc Organ Transplant Immunosuppressant Drugs Product and Service
-
14.6 AbbVie, Inc
-
14.6.1 AbbVie, Inc Company Details
-
14.6.2 AbbVie, Inc Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie, Inc Organ Transplant Immunosuppressant Drugs Product and Service
-
14.7 Veloxis Pharmaceuticals
-
14.7.1 Veloxis Pharmaceuticals Company Details
-
14.7.2 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product and Service
-
14.8 GlaxoSmithKline plc
-
14.8.1 GlaxoSmithKline plc Company Details
-
14.8.2 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product and Service
-
14.9 Pfizer, Inc
-
14.9.1 Pfizer, Inc Company Details
-
14.9.2 Pfizer, Inc Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer, Inc Organ Transplant Immunosuppressant Drugs Product and Service
-
14.10 Sanofi
-
14.10.1 Sanofi Company Details
-
14.10.2 Sanofi Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sanofi Organ Transplant Immunosuppressant Drugs Product and Service
-
14.11 Bristol-Myers Squibb Company
-
14.11.1 Bristol-Myers Squibb Company Company Details
-
14.11.2 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Product and Service
-
14.12 F Hoffmann-La Roche Ltd
-
14.12.1 F Hoffmann-La Roche Ltd Company Details
-
14.12.2 F Hoffmann-La Roche Ltd Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 F Hoffmann-La Roche Ltd Organ Transplant Immunosuppressant Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Organ Transplant Immunosuppressant Drugs
-
Figure Organ Transplant Immunosuppressant Drugs Picture
-
Table Global Organ Transplant Immunosuppressant Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Organ Transplant Immunosuppressant Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Organ Transplant Immunosuppressant Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Organ Transplant Immunosuppressant Drugs Consumption by Country (2017-2022)
-
Figure United States Organ Transplant Immunosuppressant Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Organ Transplant Immunosuppressant Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Organ Transplant Immunosuppressant Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Organ Transplant Immunosuppressant Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Organ Transplant Immunosuppressant Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Organ Transplant Immunosuppressant Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Organ Transplant Immunosuppressant Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Organ Transplant Immunosuppressant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Organ Transplant Immunosuppressant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Organ Transplant Immunosuppressant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Organ Transplant Immunosuppressant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Organ Transplant Immunosuppressant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Organ Transplant Immunosuppressant Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Antiproliferative Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Calcineurin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global mTOR Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Steroids Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Marrow Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Heart Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Transplant Consumption and Growth Rate (2017-2022)
-
Figure Global Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiproliferative Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Calcineurin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global mTOR Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Steroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone Marrow Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Heart Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Transplant Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Organ Transplant Immunosuppressant Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Organ Transplant Immunosuppressant Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table Hoffmann-La Roche Ltd Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann-La Roche Ltd Organ Transplant Immunosuppressant Drugs Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Organ Transplant Immunosuppressant Drugs Product and Service
-
Table Astellas Pharma, Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma, Inc Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma, Inc Organ Transplant Immunosuppressant Drugs Product and Service
-
Table Janssen Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Product and Service
-
Table Allergan plc (Foundation Year, Company Profile and etc.)
-
Table Allergan plc Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan plc Organ Transplant Immunosuppressant Drugs Product and Service
-
Table AbbVie, Inc (Foundation Year, Company Profile and etc.)
-
Table AbbVie, Inc Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie, Inc Organ Transplant Immunosuppressant Drugs Product and Service
-
Table Veloxis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product and Service
-
Table Pfizer, Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc Organ Transplant Immunosuppressant Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Organ Transplant Immunosuppressant Drugs Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Organ Transplant Immunosuppressant Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Organ Transplant Immunosuppressant Drugs Product and Service
-
